Description the Geriatric Intervention Contribution on Quality of Life of Elderly Patients With Metastatic Neoplasia : Prospective Descriptive Non-comparative Cohort ( QUALI Cohort)
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Systemic Treatment
- Sponsor
- Institut de Cancérologie de la Loire
- Enrollment
- 28
- Locations
- 1
- Primary Endpoint
- Level of quality of life
- Status
- Terminated
- Last Updated
- 5 years ago
Overview
Brief Summary
The aim of this study is to describe the impact of : Geriatric intervention contribution on quality of life of elderly patients receiving systemic treatments for metastatic neoplasia
Detailed Description
Elderly cancer incidence increases exponentially with advancing age. However, elderly patients are largely underrepresented in cancer treatment trials. The geriatric population presents particular physical, mental, psychological or social specificities that may condition the prognosis especially for patients with metastatic neoplasia. Recently, the measurement of quality of life (QoL) in aging population is being recognized as an important part of clinical decision. It is therefore essential to set up prospective studies to evaluate the impact of oncogeriatric practices on the quality of life of elderly patients with metastatic neoplasia. The main objective of this prospective study is to describe the contribution of geriatric intervention on quality of life for for elderly (\> 75 years) with metastatic solid cancer receiving systemic treatment during the first 6 months of their therapeutic management.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patient with solid metastatic neoplasia
- •75 years old or more
- •Men or women
- •ECOG between 0 and 3
- •Patient receiving systemic antineoplasic treatment (chemotherapy, hormonotherapy, immunotherapy, targeted therapy)
Exclusion Criteria
- •Localized cancer
- •Patients already included in a study witch could modify quality of life
- •Patient unable to give their consent
Outcomes
Primary Outcomes
Level of quality of life
Time Frame: 6 months
Level of quality of life will be measured with the QoL Q30 (Quality Qf Life with 30 Questions)
Secondary Outcomes
- Duration of hospitalizations(6 months)
- Number of toxicities ( grade 3 and 4)(6 months)
- number of hospitalizations(6 months)